Public health genomics and genetic test evaluation: The challenge of conducting behavioural research on the utility of lifestyle-genetic tests

Journal of Nutrigenetics and Nutrigenomics

Volumn 1, Issue 5, 2008, Pages 224-231

  Sanderson, Saskia C ^a,b   Wardle, Jane ^b   Humphries, Steve E ^b,c  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Centre for Cardiovascular Disease   (United Kingdom)

Author keywords

Clinical utility; Genetic testing; Health behaviours; Lifestyle; Public health genomics

Indexed keywords

BEHAVIOR CHANGE; BEHAVIORAL RESEARCH; DNA DETERMINATION; GENETIC ANALYSIS; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; HEALTH BEHAVIOR; HUMAN; LIFESTYLE MODIFICATION; OBESITY; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; UNITED KINGDOM; WEIGHT REDUCTION;

BEHAVIOR; COMMERCE; EPIDEMIOLOGIC RESEARCH DESIGN; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOMICS; GREAT BRITAIN; HUMANS; LIFE STYLE; PUBLIC HEALTH; REAGENT KITS, DIAGNOSTIC;

EID: 50249148346     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000149826     Document Type: Review

References (56)

1. The International HapMap Consortium: A haplotype map of the human genome. Nature 2005;437:1299-1320.
2. Sachidanandam R, et al: A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001;409:928-933.
3. Collins FS, Morgan M, Patrinos A: The Human Genome Project: lessons from large-scale biology. Science 2003;300:286-290.
4. Cordell HJ, Clayton DG: Genetic association studies. Lancet 2005;366:1121-1131.
5. Davey SG, et al: Genetic epidemiology and public health: hope, hype, and future prospects: Lancet 2005;366:1484-1498.
6. Collins FS, Green ED, Guttmacher AE, Guyer MS: A vision for the future of genomics research. Nature 2003;422:835-847.
7. Khoury MJ, Davis R, Gwinn M, Lindegren ML, Yoon P: Do we need genomic research for the prevention of common diseases with environmental causes? Am J Epidemiol 2005;161:799-805.
8. Marteau TM, Weinman J: Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med 2006;62:1360-1368.
9. Collins FS: The human genome project and the future of medicine. Ann NY Acad Sci 1999;882:42-55.
10. Collins FS: Shattuck Lecture - medical and societal consequences of the Human Genome Project. N Engl J Med 1999;341:28-37.
11. Gerich JE: The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocrinol Rev 1998;19:491-503.
12. Hitman GA, Sudagani J: Searching for genes in diabetes and the metabolic syndrome. Int J Clin Pract Suppl 2004;143:3-8.
13. Lyssenko V, et al: Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 2005;54:166-174.
14. Grant SF, et al: Variant of transcription factor 7-like 2 TCF7L2 gene confers risk of type 2 diabetes. Nat Genet 2006;38:320-323.
15. Wade N: Gene Increases Diabetes Risk, Scientists Find. New York, New York Times, 2006.
16. Janssens AC, Gwinn M, Valdez R, Narayan KM, Khoury MJ: Predictive genetic testing for type 2 diabetes. BMJ 2006;333:509-510.
17. Cooper RS, Psaty BM: Genomics and medicine: distraction, incremental progress, or the dawn of a new age? Ann Intern Med 2003;138:576-580.
18. Merikangas KR, Risch N: Genomic priorities and public health. Science 2003;302:599-601.
19. Merikangas KR, Risch N: Will the genomics revolution revolutionize psychiatry? Am J Psychiatry 2003;160:625-635.
20. Willett WC: Balancing life-style and genomics research for disease prevention. Science 2002;296:695-698.
21. Burke W, Khoury MJ, Stewart A, Zimmern RL: The path from genome-based research to population health: development of an international public health genomics network. Genet Med 2006;8:451-458.
22. Grosse SD, Khoury MJ: What is the clinical utility of genetic testing? Genet Med 2006;8:448-450.
23. Haga SB, Khoury MJ, Burke W: Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nat Genet 2003;34:347-350.
24. Khoury MJ, Jones K, Grosse SD: Quantifying the health benefits of genetic tests: the importance of a population perspective. Genet Med 2006;8:191-195.
25. Scheuner MT, Rotter JI: Quantifying the health benefits of genetic tests: a clinical perspective. Genet Med 2006;8:141-142.
26. Mutch DM, Wahli W, Williamson G: Nutrigenomics and nutrigenetics: the emerging faces of nutrition. FASEB J 2005;19:1602-1616.
27. Ordovas JM: Nutrigenetics, plasma lipids, and cardiovascular risk. J Am Diet Assoc 2006;106:1074-1081.
28. Roberts G, Grimaldi K: Sciona and genetic testing. Nat Genet 2003;33:121.
29. Vineis P, Christiani DC: Genetic testing for sale. Epidemiology 2004;15:3-5.
30. Mykitiuk R: Caveat emptor: direct-to-consumer supply and advertising of genetic testing. Clin Invest Med 2004;27:23-32.
31. Marteau TM, Lerman C: Genetic risk and behavioural change. BMJ 2001;322:1056-1059.
32. Holtzman NA: Are genetic tests adequately regulated? Science 1999;286:409.
33. Holtzman NA: Promoting safe and effective genetic tests in the United States: work of the task force on genetic testing. Clin Chem 1999;45:732-738.
34. Khoury MJ, et al: Challenges in communicating genetics: a public health approach. Genet Med 2000;2:198-202.
35. Burke W, Pinsky LE, Press NA: Categorizing genetic tests to identify their ethical, legal, and social implications. Am J Med Genet 2001;106:233-240.
36. Harvey-Berino J, et al: Does genetic testing for obesity influence confidence in the ability to lose weight? A pilot investigation. J Am Diet Assoc 2001;101:1351-1353.
37. Frosch DL, Mello P, Lerman C: Behavioral consequences of testing for obesity risk. Cancer Epidemiol Biomarkers Prev 2005;14:1485-1489.
38. Audrain J, et al: Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. Addict Behav 1997;22, 741-751.
39. Lerman C, et al: Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol 1997;16:87-99.
40. Sanderson SC, Humphries SE, Hubbart C, Hughes E, Jarvis MJ, Wardle J: Psychological and behavioural impact of genetic testing smokers for lung cancer risk: a phase II exploratory trial. J Health Psychol 2008;13:481-494.
41. McBride CM, et al: Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev 2002;11:521-528.
42. Sanderson SC, Michie S: Genetic testing for heart disease susceptibility: potential impact on intention to quit smoking. Clin Genet 2007;71:501-510.
43. Wang C, Bowen DJ, Kardia SL: Research and practice opportunities at the intersection of health education, health behavior, and genomics. Health Educ Behav 2005;32:686-701.
44. Campbell M, et al: Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694-696.
45. Gollust SE, Hull SC, Wilfond BS: Limitations of direct-to-consumer advertising for clinical genetic testing. JAMA 2002;288;1762-1767.
46. McBride CM, et al: Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit. J Health Commun 2000;5:229-241.
47. Lipkus IM, McBride CM, Pollak KI, et al: Interpretation of genetic risk feedback among African-American smokers with low socioeconomic status. Health Psychol 2004;23:178-188.
48. Gooding HC, Organista K, Burack J, Biesecker BB: Genetic susceptibility testing from a stress and coping perspective. Soc Sci Med 2006;62:1880-1890.
49. Bates BR, Templeton A, Achter PJ, et al: What does 'a gene for heart disease' mean? A focus group study of public understandings of genetic risk factors. Am J Med Genet A 2003;119:156-161.
50. Senior V, Marteau TM, Peters TJ: Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia. Soc Sci Med 1999;48:1857-1860.
51. McBride CM, Lipkus IM, Jolly D, Lyna P: Interest in testing for genetic susceptibility to lung cancer among Black college students 'at risk' of becoming cigarette smokers. Cancer Epidemiol Biomarkers Prev 2005;14:2978-2981.
52. Sanderson SC, Wardle J, Jarvis MJ, Hum - phries SE: Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK. Prev Med 2004;39:458-464.
53. Sanderson S, et al: How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genet Med 2005;7:495-500.
54. Bowen DJ, Battuello KM, Raats M: Marketing genetic tests: empowerment or snake oil? Health Educ Behav 2005;32:676-685.
55. Zimmern R, Emery J, Richards T: Putting genetics in perspective requires better understanding and more rational debate. BMJ 2001;322:1005-1006.
56. Morris J, Gwinn M, Clyne M, Khoury MJ: Public knowledge regarding the role of genetic susceptibility to environmentally induced health conditions. Community Genet 2003;6:22-28.